Mutagenic Impurities

Mutagenic Impurities
Author :
Publisher : John Wiley & Sons
Total Pages : 548
Release :
ISBN-10 : 9781119551218
ISBN-13 : 1119551218
Rating : 4/5 (18 Downloads)

Book Synopsis Mutagenic Impurities by : Andrew Teasdale

Download or read book Mutagenic Impurities written by Andrew Teasdale and published by John Wiley & Sons. This book was released on 2022-02-15 with total page 548 pages. Available in PDF, EPUB and Kindle. Book excerpt: Learn to implement effective control measures for mutagenic impurities in pharmaceutical development In Mutagenic Impurities: Strategies for Identification and Control, distinguished chemist Andrew Teasdale delivers a thorough examination of mutagenic impurities and their impact on the pharmaceutical industry. The book incorporates the adoption of the ICH M7 guideline and focuses on mutagenic impurities from both a toxicological and analytical perspective. The editor has created a primary reference for any professional or student studying or working with mutagenic impurities and offers readers a definitive narrative of applicable guidelines and practical, tested solutions. It demonstrates the development of effective control measures, including chapters on the purge tool for risk assessment. The book incorporates a discussion of N-Nitrosamines which was arguably the largest mutagenic impurity issue ever faced by the pharmaceutical industry, resulting in the recall of Zantac and similar drugs resulting from N-Nitrosamine contamination. Readers will also benefit from the inclusion of: A thorough introduction to the development of regulatory guidelines for mutagenic and genotoxic impurities, including a historical perspective on the development of the EMEA guidelines and the ICH M7 guideline An exploration of in silico assessment of mutagenicity, including use of structure activity relationship evaluation as a tool in the evaluation of the genotoxic potential of impurities A discussion of a toxicological perspective on mutagenic impurities, including the assessment of mutagenicity and examining the mutagenic and carcinogenic potential of common synthetic reagents Perfect for chemists, analysts, and regulatory professionals, Mutagenic Impurities: Strategies for Identification and Control will also earn a place in the libraries of toxicologists and clinical safety scientists seeking a one-stop reference on the subject of mutagenic impurity identification and control.


Mutagenic Impurities Related Books

Mutagenic Impurities
Language: en
Pages: 548
Authors: Andrew Teasdale
Categories: Medical
Type: BOOK - Published: 2022-02-15 - Publisher: John Wiley & Sons

DOWNLOAD EBOOK

Learn to implement effective control measures for mutagenic impurities in pharmaceutical development In Mutagenic Impurities: Strategies for Identification and
Genotoxic Impurities
Language: en
Pages: 455
Authors: Andrew Teasdale
Categories: Medical
Type: BOOK - Published: 2011-03-29 - Publisher: John Wiley & Sons

DOWNLOAD EBOOK

This book examines genotoxic impurities and their impact on the pharmaceutical industry. Specific sections examine this from both a toxicological and analytical
ICH Quality Guidelines
Language: en
Pages: 624
Authors: Andrew Teasdale
Categories: Medical
Type: BOOK - Published: 2017-09-29 - Publisher: John Wiley & Sons

DOWNLOAD EBOOK

Examining the implications and practical implementation of multi-disciplinary International Conference on Harmonization (ICH) topics, this book gives an integra
Mutagenicity: Assays and Applications
Language: en
Pages: 352
Authors: Ashutosh Kumar
Categories: Science
Type: BOOK - Published: 2017-09-26 - Publisher: Academic Press

DOWNLOAD EBOOK

Mutagenicity: Assays and Applications presents an extensive examination of the detection, assessment and future of mutagenicity, particularly as it concerns hum
Development and Validation of Analytical Methods
Language: en
Pages: 363
Authors: Christopher M. Riley
Categories: Science
Type: BOOK - Published: 1996-05-29 - Publisher: Elsevier

DOWNLOAD EBOOK

The need to validate an analytical or bioanalytical method is encountered by analysts in the pharmaceutical industry on an almost daily basis, because adequatel